Juya, F.; Klemmetsby Solli, K.; Sannes, A.-C.; Weimand, B.; Gjerstad, J.; Tanum, L.; Mordal, J.
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study. Brain Sci. 2026, 16, 23.
https://doi.org/10.3390/brainsci16010023
AMA Style
Juya F, Klemmetsby Solli K, Sannes A-C, Weimand B, Gjerstad J, Tanum L, Mordal J.
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study. Brain Sciences. 2026; 16(1):23.
https://doi.org/10.3390/brainsci16010023
Chicago/Turabian Style
Juya, Farid, Kristin Klemmetsby Solli, Ann-Christin Sannes, Bente Weimand, Johannes Gjerstad, Lars Tanum, and Jon Mordal.
2026. "Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study" Brain Sciences 16, no. 1: 23.
https://doi.org/10.3390/brainsci16010023
APA Style
Juya, F., Klemmetsby Solli, K., Sannes, A.-C., Weimand, B., Gjerstad, J., Tanum, L., & Mordal, J.
(2026). Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study. Brain Sciences, 16(1), 23.
https://doi.org/10.3390/brainsci16010023